A Phase II Study to Evaluate the Efficacy, Safety and Pharmacodynamics of Lapatinib in Patients With Relapsed or Refractory Inflammatory Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2015
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2008 Final results presented at ASCO 2008.
- 08 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.